Fulgent Genetics, Inc. (FLGT) Tops Q4 EPS by 22c

Fulgent Genetics, Inc. (NASDAQ: FLGT) reported Q4 EPS of $0.16, $0.22 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $83.3 million versus the consensus estimate of $84.5 million.

For earnings history and earnings-related data on Fulgent Genetics, Inc. (FLGT) click here.

You May Also Be Interested In

• Apple investigating exposure to Tata Electronics data breach, full analysis underway - Reuters
• Definium Therapeutics Inc (DFTX) PT Raised to $60 at Oppenheimer
• Popular stocks with increasing option volume: SPCX INTC AVGO AMC MU PLTR NYT